logo-loader

Proactive events

Our next online investor event

25 August 2020 | New York

Webinar Jam - Virtual

Hearing the inside story and understanding the team behind the performance is crucial to making informed decisions. Join us at our next Proactive event to see leading growth companies make their pitch

Leading companies pitching

1538058873_biocept-logo-FINwTag
Biocept Inc

Biocept, Inc. is a leading commercial provider of liquid biopsy tests designed to provide physicians with clinically actionable information to improve the outcomes of patients diagnosed with cancer. The company's patented Target Selector liquid...

1577989765_Screenshot-at-Jan-02-10-28-09
Starton Therapeutics

Starton Therapeutics Inc is a privately-owned, clinical-stage biotechnology company focused on transforming standard-of-care therapeutics.  New Jersey-based Starton is developing a proprietary, continuous delivery once-weekly transdermal patch...

1615319624_logo
Todos Medical Ltd.

Todos Medical Ltd, founded in Rehovot, Israel with offices in New York City, engineers life-saving diagnostic solutions for the early detection of a variety of cancers. In 2021, Todos completed the acquisition of US-based medical diagnostics...

gevo
Gevo Inc

Gevo is a next generation “low-carbon” fuel company focused on the development and commercialization of renewable alternatives to petroleum-based products. Low-carbon fuels reduce the carbon intensity, or the level of greenhouse gas emissions,...

Meet the real story

Join our audience of astute high net worth investors, fund managers, private client brokers and analysts

Look beyond the numbers and meet the people creating the value for shareholders

Each company has a presentation slot followed by Q & A, giving you the chance to discover the real story

Watch the event afterwards on our YouTube channel

Proactive events

The best event for investors looking for the insights that keep you a step ahead of the crowd

See more Proactive events >

One2one investor forums are suitable for sophisticated private investors, private client brokers, fund managers, financial institutions, hedge funds, buy and sell side analysts and journalists. The event is not suitable for people pursuing commercial opportunities.